A phase 3 trial in lung cancer, run by Fudan University, now recruiting.
Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) is a phase 3, interventional study registered as NCT06031181 by Fudan University, with a registry enrolment figure of 390 participants, started 2023-03-31 and due to reach its primary completion in 2026-01-01. Interventions recorded: Sublobar Resection. Conditions listed: Lung Adenocarcinoma; Frozen Section; Sublobar Resection. Primary outcome: 5-year recurrence-free survival. Lung eligibility wording from the registry: "Not receiving lung cancer surgery before;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.